Genetic alterations may predict everolimus efficacy The Oncology Report SAN FRANCISCO – Among postmenopausal women with advanced hormone receptor–positive breast cancer, everolimus appeared to be more effective in the patients with one or no alterations in four key genes. In a secondary analysis of data from the ... |
